BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24503463)

  • 1. Glassy cell carcinoma of the cervix: a systematic review and meta-analysis.
    Guitarte C; Alagkiozidis I; Mize B; Stevens E; Salame G; Lee YC
    Gynecol Oncol; 2014 May; 133(2):186-91. PubMed ID: 24503463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix?
    Shingleton HM; Bell MC; Fremgen A; Chmiel JS; Russell AH; Jones WB; Winchester DP; Clive RE
    Cancer; 1995 Nov; 76(10 Suppl):1948-55. PubMed ID: 8634986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glassy cell carcinoma of the uterine cervix: 20-year experience from a comprehensive cancer center.
    Boustani J; Achkar S; Bertaut A; Genestie C; Gouy S; Pautier P; Morice P; Haie-Meder C; Chargari C
    Cancer Radiother; 2021 May; 25(3):207-212. PubMed ID: 33408051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glassy cell carcinoma of the cervix: Findings from a combined National Cancer Database analysis and single institution review of treatment patterns and outcomes.
    Levine MD; Barrington DA; Meade CE; Lammers SM; McLaughlin EM; Suarez AA; Backes FJ; Copeland LJ; O'Malley DM; Cosgrove CM; Cohn DE; Nagel CI; Felix AS; Bixel KL
    Gynecol Oncol; 2023 Jun; 173():15-21. PubMed ID: 37037083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
    Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
    Farley JH; Hickey KW; Carlson JW; Rose GS; Kost ER; Harrison TA
    Cancer; 2003 May; 97(9):2196-202. PubMed ID: 12712471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
    Stock RG; Chen AS; Karasek K
    Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical analysis of 21 cases of cervical adenosquamous carcinoma].
    Cai HN; Wu XF; Xiang QY; Xiong YY; Zeng J
    Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):124-7. PubMed ID: 18683752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multimodal treatment for glassy cell carcinoma of the uterine cervix.
    Nasu K; Takai N; Narahara H
    J Obstet Gynaecol Res; 2009 Jun; 35(3):584-7. PubMed ID: 19527406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosquamous carcinoma of the cervix: prognosis in early stage disease treated by radical hysterectomy.
    Harrison TA; Sevin BU; Koechli O; Nguyen HN; Averette HE; Penalver M; Donato DM; Nadji M
    Gynecol Oncol; 1993 Sep; 50(3):310-5. PubMed ID: 8406193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma.
    Werner-Wasik M; Schmid CH; Bornstein L; Ball HG; Smith DM; Madoc-Jones H
    Int J Radiat Oncol Biol Phys; 1995 Jul; 32(5):1309-17. PubMed ID: 7635770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma.
    Schefter T; Winter K; Kwon JS; Stuhr K; Balaraj K; Yaremko BP; Small W; Sause W; Gaffney D;
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):101-5. PubMed ID: 24331655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
    Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
    Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of patients with incomplete resection after surgery for stage IB2/II cervical carcinoma with chemoradiation therapy.
    Uzan C; Vincens E; Balleyguier C; Gouy S; Pautier P; Duvillard P; Haie-Meder C; Morice P
    Int J Gynecol Cancer; 2010 Apr; 20(3):379-84. PubMed ID: 20375801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glassy cell carcinoma: a rare cervical neoplasm. Case report of two patients and review of the literature].
    LĂ©pinoy A; Lescut N; Lassabe C; Bosset JF; Servagi-Vernat S
    Cancer Radiother; 2014 Jun; 18(3):211-4. PubMed ID: 24819246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors and adjuvant therapy on survival in early-stage cervical adenocarcinoma/adenosquamous carcinoma after primary radical surgery: A Taiwanese Gynecologic Oncology Group (TGOG) study.
    Twu NF; Ou YC; Liao CI; Chang WY; Yang LY; Tang YH; Chen TC; Chen CH; Chen TH; Yeh LS; Hsu ST; Chen YC; Chang CC; Cheng YM; Huang CY; Liu FS; Lin YS; Hsiao SM; Kan YY; Lai CH
    Surg Oncol; 2016 Sep; 25(3):229-35. PubMed ID: 27566027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognosis analysis of 83 cases of cervical adenosquamous carcinoma].
    Yan M; Zhang YN; He JH; Huang H
    Ai Zheng; 2008 Sep; 27(9):956-61. PubMed ID: 18799035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.
    Yokoi E; Mabuchi S; Takahashi R; Matsumoto Y; Kuroda H; Kozasa K; Kimura T
    J Gynecol Oncol; 2017 Mar; 28(2):e19. PubMed ID: 28028992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.
    Hille A; Weiss E; Hess CF
    Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.